This section includes information and resources about Diabetes for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.
Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe
Boehringer Ingelheim and Zealand Pharma enter into a licence and collaboration agreement to advance novel compounds to treat Type-2 diabetes and obesity
FDA approves linagliptin tablets for the treatment of type 2 diabetes
Boehringer Ingelheim and Eli Lilly and Company Announce Strategic Alliance to Bring New Diabetes Treatments to Patients Worldwide
Boehringer Ingelheim steps up to the challenge in support of World Diabetes Day
Diabetes Related News Room